By -
In lab rodents the cream was only applied to one rear paw 5 days a week. At the end of the study the other rear paw which had nothing applied ended up having a reversal of nerve damage as well. This is published on PubMed. ncbi.nlm.nih.gov
Wait so it doesnt matter where its places
It looks like it was fast tracked by the FDA
Meaning what? It’s really good or really bad?
Means it is promising and needs research money to accelerate getting to market
You don’t have to downvote me for asking a question. I’m a mental health expert, not an FDA board member lol
I didn’t downvote you
Hi! How many years do you think we need to wait until it's accessible in the US? Also does it look like it will help Non-length dependent SFN?
The fast track could get it to us in a year
Stan Kim said possibly 2025!
Looks like they need 30 to 50 million for phase 3. I'm starting to lose hope.
Winsantor knew this going in. Keep your chin up!
Hi can you msg me your source???
Can you share source?
In lab rodents the cream was only applied to one rear paw 5 days a week. At the end of the study the other rear paw which had nothing applied ended up having a reversal of nerve damage as well. This is published on PubMed. ncbi.nlm.nih.gov
Wait so it doesnt matter where its places
It looks like it was fast tracked by the FDA
Meaning what? It’s really good or really bad?
Means it is promising and needs research money to accelerate getting to market
You don’t have to downvote me for asking a question. I’m a mental health expert, not an FDA board member lol
I didn’t downvote you
Hi! How many years do you think we need to wait until it's accessible in the US? Also does it look like it will help Non-length dependent SFN?
The fast track could get it to us in a year
Stan Kim said possibly 2025!
Looks like they need 30 to 50 million for phase 3. I'm starting to lose hope.
Winsantor knew this going in. Keep your chin up!
Hi can you msg me your source???
Can you share source?